Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1994-09-26
1995-07-04
Naff, David M.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
424 946, 424 9461, 435814, 435815, C12N 916, A61K 3754
Patent
active
054299373
ABSTRACT:
Intestinal cell endogenous heparin mediated absorption of cholesterol or fatty acids in mammals is inhibited through the oral administration of heparin, an active heparin subfraction or heparinase. Suppression of cholesterol esterase-mediated absorption in humans can be inhibited by soluble heparin by two mechanisms, i.e. displacement of the enzyme from the intestinal cell membrane and inhibition of enzymatic activity of the displaced enzyme.
REFERENCES:
patent: 4011138 (1977-03-01), Terada et al.
patent: 5017565 (1991-05-01), Lange, III et al.
patent: 5063210 (1991-11-01), Lange, III et al.
patent: 5173408 (1992-12-01), Lange, III et al.
patent: 5352601 (1994-10-01), Lange, III et al.
Bosuer et al., Proc. Nat'l. Acad. Sci. USA, vol. 85, 7438-42, 1988.
Julien et al; Biochim. Biophys. Acta 280:215-224 (1972).
Vandermeers et al; Biochim. Biophys. Acta 370: 257-268 (1974).
Matsumura et al; J. Biol. Chem. 251 (20): 6267-6273 (1976).
Breuter et al; Biochim. Biophys. Acta 530: 112-123 (1978).
Lombardo et al; Biochim. Biophys. Acta 527: 142-149 (1978).
Tuhackova et al; Biochim. Biophys. Acta 617: 439-445 (1980).
Tsujita et al; Biochim. Biophys. Acta 715: 181-188 (1982).
Durham, III et al; J. Biol. Chem. 259 (12): 7433-7438 (1984).
Treadwell et al., in Handbook of Physiology, Section 6, vol. III (1968) pp. 1407-1438.
Brockerhoff et al., in Lipolytic Enzymes, Chp. 5 (Academic Press, 1974) pp. 176-193.
Rudd et al., in Lipases (Elsevier, N.Y., 1984) pp. 185-204.
Calame et al., (1975) Arch. Bioch. Biophys. 168: 57-65.
Van den Bosch et al., (1973) Biochem. Biophys. Acta. 296: 94-104.
Momsen et al., (1977) Biochem. Biophys. Acta. 486: 103-113.
Guy et al., (1981) Eur. J. Biochem. 117: 457-460.
Casdorph H. R., in Lipid Pharmocology (Academic Press, 1976) pp. 221-256.
Ayotte and Perlin, (1986) Carbohydrate Res. 145: 267-277.
Cardin et al., (1984) Thrombosis Res. 34: 541-550.
Kinnunen Paula M.
Lange, III Louis G.
Spilburg Curtis A.
CV Therapeutics
Meller Michael V.
Naff David M.
LandOfFree
Method for recovering purified 100,000 molecular weight fraction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for recovering purified 100,000 molecular weight fraction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for recovering purified 100,000 molecular weight fraction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-759423